跳至主要内容
临床试验/NCT03962790
NCT03962790已完成不适用

Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing Technology

Johnson & Johnson Vision Care, Inc.6 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2019年5月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
95
试验地点
6
主要终点
Overall Comfort Score

研究概览

简要总结

This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear both Test and Control lenses in each eye in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • •The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  • •Appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • •Must be at least 18 and not more than 70 years of age (including 70) at the time of screening.
  • •The subject must be a habitual and adapted wearer of hydrogel daily disposable brand contact lenses in both eyes (at least 1 month of daily wear).
  • •The subject must have normal eyes (i.e., no ocular medications or infections of any type).
  • •The subject's required spherical contact lens prescription must be in the range of -0.50 to -6.00 D in each eye.
  • •The subject's refractive cylinder must be < 0.75D in each eye.
  • •The subject must have best corrected visual acuity of 20/25 or better in each eye.

排除标准

  • •Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • •Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
  • •Any systemic disease, autoimmune disease, or use of medication that may interfere with contact lens wear.
  • •Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.).
  • •Any ocular infection.
  • •Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • •Monovision or multi-focal contact lens correction.
  • •Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
  • •History of binocular vision abnormality or strabismus.
  • •Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV, by self-report).
  • •Suspicion of or recent history of alcohol or substance abuse.
  • •History of serious mental illness.
  • •History of seizures.
  • •Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician)
  • •Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion
  • •Any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the Food and Drug Administration (FDA) classification scale
  • •Any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.

研究组 & 干预措施

Test/Control

Experimental

Eligible subjects that are habitual wearers of hydrogel daily disposable contact lenses in both eyes will be randomly assigned to one of two sequences, (Test/Control) or (Control/Test).

干预措施: 1-DAY ACUVUE® MOIST (Device)

Control/Test

Experimental

Eligible subjects that are habitual wearers of hydrogel daily disposable contact lenses in both eyes will be randomly assigned to one of two sequences, (Test/Control) or (Control/Test).

干预措施: 1-DAY ACUVUE® MOIST (Device)

结局指标

主要结局

Overall Comfort Score

时间窗: 1-Week Follow-up

Overall comfort score was assessed using the Contact Lens User Experience (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (standard deviation \[SD\] 20), where higher scores indicate a more favorable/positive response. A 5-point increase in an average CLUE score translates into 10% shift in the distribution of scores for the population of soft disposable contact lens wearers.

Overall Vision Score

时间窗: 1-Week Follow-up

Overall quality of vision was assessed using the Contact Lens User Experience (CLUE) questionnaire. CLUE is a validated patient reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. A 5-point increase in an average CLUE score translates into 10% shift in the distribution of scores for the population of soft disposable contact lens wearers.

次要结局

  • LogMAR Visual Performance Scale(1-Week follow-up)
  • Average Daily Wear Time(1-Week follow-up)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验